Article

Untangling neuroimaging modalities key for surgeons

Computed tomography and magnetic resonance imaging are extremely important imaging modalities with different capabilities that the ophthalmic surgeon should understand to use to the best advantage, according to Neil R. Miller, MD.

Key Points

The main radiologic neuroimaging studies currently used are computed tomography (CT) and CT angiography (CTA). The nonradiologic imaging studies are magnetic resonance imaging (MRI), MR angiography (MRA), ultrasonography, and optical coherence tomography, according to Dr. Miller, who emphasized that every imaging modality has strengths and weaknesses; no one method is perfect.

"The test a clinician should request is the test that will answer the question he or she [faces]," said Dr. Miller, professor of ophthalmology, neurology, neurosurgery, and neuro-ophthalmology, Johns Hopkins Medical Institutions, Baltimore. "The clinician cannot just order, for example, a CT scan or MRI. The radiologist or neuroradiologist must be told what the clinician is looking for.

CT is best for imaging of the orbit because it shows not only soft-tissue lesions but also the bony anatomy. It is also excellent for imaging of the paranasal sinuses, large intracranial lesions both above and below the tentorium, and subarachnoid and intracranial hemorrhage.

CT is less useful for imaging of optic chiasmal lesions, brainstem lesions, and small lesions in the cerebral hemispheres or posterior fossa, however. If using enhancement with iodinated contrast material, there is the potential for severe reactions to the contrast agent, Dr. Miller said.

"[CT] is the best imaging test for presumed orbital lesions, bony anatomy, and the paranasal sinuses, but the correct images must be obtained, which means thin sections on occasion and direct or re-formatted coronal views. Contrast material is rarely needed in the orbit," he said.

In the examples he provided, Dr. Miller noted that relationships to bone are extremely important. In one image, the lesion was immediately adjacent to bone with remodeling of the bone, indicating that the lesion was extraperiosteal, which pinpoints the location for the physician.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
© 2025 MJH Life Sciences

All rights reserved.